Xencor, Inc. Expected to Post FY2023 Earnings of ($1.09) Per Share (NASDAQ:XNCR)

Xencor, Inc. (NASDAQ:XNCR – Get Rating) – Investment analysts at Cantor Fitzgerald issued their FY2023 EPS estimates for Xencor in a research note issued to investors on Monday, May 15th. Cantor Fitzgerald analyst P. Stavropoulos expects that the biopharmaceutical company will post earnings of ($1.09) per share for the year. Cantor Fitzgerald currently has a […]

Related Keywords

New York ,United States ,Allen Yang ,Johnj Kuch ,Kokusai Asset Management Co ,Securities Exchange Commission ,Xencor Company Profile ,Cantor Fitzgerald ,Ef Hutton Acquisition Co ,York State Common Retirement Fund ,Dimensional Fund Advisors ,Mitsubishi Ufj ,Canaccord Genuity Group ,Xencor Inc ,Nasdaq ,Sg Americas Securities ,Get Rating ,Genuity Group ,Stock Down ,Fund Advisors ,Asset Management ,New York State Common Retirement Fund ,Exchange Commission ,Xencor Daily ,Xencor ,Nasdaq Xncr ,Xncr ,Medical ,Earnings Estimates ,